News
December 6, 2022
OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations
June 21, 2022
OnKure Therapeutics Appoints Kevin S. Litwiler, Ph.D., as Senior Vice President of DMPK and Clinical Pharmacology
June 2, 2022
OnKure Therapeutics Announces First Patient Dosed in the Phase 1b/2 Nautilus Trial of OKI-179 in Combination with Binimetinib in Patients with Advanced NRAS-Mutated Melanoma
- View All News